Already sky high after the success of its limb-girdle muscular dystrophy therapy, reported on Monday, BridgeBio’s shares rose nearly 8% more as encaleret balanced calcium levels in patients with a ...

Police walk past a burned car used as a roadblock during a police operation against alleged drug traffickers in the Complexo ...

Researchers assessed the quality of life measures of patients with thyroid eye disease treated with Veligrotug, a full antagonist humanized mAb to IGF-1R.

Investing.com -- The U.S. Food and Drug Administration has eliminated the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa, a thyroid cancer medication made by Sanofi’s Genzyme.

Health care providers are encouraged to contact patients prescribed unapproved thyroid medications to transition them to FDA-approved medications. The Food and Drug Administration (FDA) is warning the ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...